ranolazine
ranolazine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Ranolazine. Available dosage forms: tablet, film coated, extended release, powder.
Drug Details
- Generic Name
- ranolazine
- Brand Names
- Ranolazine
- Application Number
- ANDA213085
- Sponsor
- Zameer Pharmaceuticals LLC
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE, POWDER
- Routes
- ORAL
- Active Ingredients
- RANOLAZINE
Indications and Usage
1 INDICATIONS AND USAGE Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 )